PARSIPPANY, N.J., Dec. 01, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (EMBC), a global diabetes care company, today issued the following statement regarding the U.S. Food and Drug Administration (FDA) ...
(MENAFN- GlobeNewsWire - Nasdaq) PARSIPPANY, N.J., Dec. 01, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company, today issued the following statement ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results